IESE (España)
-
Iluminum, S.A.
Lopetegui G.; Parés Canalias, Francisco; Renart, Lluís G.Case M-678-EMarketingStarting at €8.20
-
Bausch & Lomb India
Parés Canalias, Francisco; Renart, Lluís G.; Sahay S.Case M-962-EMarketingIn May 1990, Bausch & Lomb decided to launch a new subsidiary in India. A new plant was set up in Bhiwadi to manufacture soft contact lenses, eyecare, products, metallic frames for prescription glasses, and the leding premium sunglasses in the world: Ray-Ban. The launch took place between July and October, 1991. In June 1993, actual sales achievement is below forecast, and the managers of the Indian subsidiary are considering the opportunity to l...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Iluminum, S.A.
Lopetegui G.; Parés Canalias, Francisco; Renart, Lluís G.Case M-678MarketingIluminum, S.A. es una empresa dedicada a la fabricación y venta de artículos para iluminación fundada en 1967. El caso describe los primeros pasos hacia la exportación. Tras unos tanteos infructuosos en Sudamérica (1982), la empresa es contactada por unos norteamericanos. El contenido principal del caso se centra en los esfuerzos de penetración del mercado USA, en el cual parece haber muy buenas perspectivas. Sin embargo, a pesar de haber nombrad...Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20